Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Investors Business Daily

Stock Market Slides After Mixed Bank Earnings, Meta Downgrade, Google's AI Trauma

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

Investors Business Daily

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Markets Today: Stock Index Futures Mixed on Pressure from Higher Bond Yields

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.03%. U.S. stock index futures this morning are mixed. An increase in M&A activity is positive for stocks after Merck said it would acquire Prometheus Biosciences for...

Barchart

Stocks Nudge Higher, Earnings On Deck, Merck Buys Prometheus, Netflix Axes 'Love Is Blind', Charles Schwab Reports - Five Things To Know

Stock futures edge higher with earnings, treasury yields in focus; Week Ahead: busy earnings week, housing data on deck; Prometheus Biosciences soars after $10.8 billion Merck takeover; Netflix 'Love is Blind' live event scrapped after user outage and Charles Schwab earnings up next as broker weathers bank sector storm.

The Street

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Tribune News Service

Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine

Moderna stock rose Monday after European regulators granted its Merck-partnered personalized cancer vaccine a key designation.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

5 S&P 500 Stocks Near Buy Points As Recession Fears Rise

Medical stocks are holding up amid economic and market uncertainty.

Investors Business Daily

Merck Stock Today: How A Bear Call Spread Can Return 10% In Less Than One Month

The maximum loss will occur if MRK closes above 115 on April 21.

Investors Business Daily

Does the future of medicine lie in space?

Earth’s gravity makes it harder to cultivate the proteins needed to study diseases and pathogens. And although the cost of space travel is high, private enterprise is stepping in

The Guardian - UK

Insurance Agencies Would Love to Know Who Blew Up Nord Stream

An era of gray zone warfare and sabotage creates tough financial questions.

Foreign Policy

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

Bangkok Post

Dow Jones Holds Above 32,000 As Index Bounce Fades; Financials Rocked Again As Regulators Shut Down SVB Financial

The Dow Jones climbed off lows Friday, but sellers regained control amid more broad-based selling in the financial sector.

Investors Business Daily

Could Merck's Next Keytruda-Like Franchise Generate $10 Billion In Sales?

Two of Merck's new drugs could generate north of $10 billion in peak sales, an analyst said Tuesday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The New Daily

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

Insider UK

Merck Livingston announces 15 new jobs and £2.6 million investment

Strategic partnership signed with Scottish Enterprise to develop novel quality control kit

Investors Business Daily

The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks

Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

Investors Business Daily

Dow Jones Battles Key Support As Indexes Trade Near Session Lows; Sellers Hit Chevron, Salesforce

The Dow Jones held up better than the Nasdaq composite midday Friday, helped by strong showings from Amgen, Merck and Coca-Cola.

Fortune

The cost of cybersecurity insurance is soaring–and state-backed attacks will be harder to cover. It’s time for companies to take threats more seriously

State-backed attacks are on the rise–and the insurance sector is increasingly excluding them from coverage.

Investors Business Daily

Top Fund Manager Found A Way To Make Money While Others Lose

Making money in an up market is easy. But showering investors with gains when stocks fall is far more challenging for the best mutual funds.

Investors Business Daily

Merck Lands In Hot Water After 2023 Profit Guidance Widely Misses Forecasts

Merck's profit guidance for 2023 widely missed Wall Street's projections on Thursday, leading Merck stock to crumble despite a quarterly beat.

Investors Business Daily

Dow Jones Falls 275 Points After Jobless Claims; Meta Soars 20% On Strong Sales, $40 Billion Buyback

The Dow Jones fell Thursday after initial jobless claims. Meta stock soared 20% on a $40 billion stock buyback.

The Street

Merck Stock Slumps As 2023 Profit Outlook Clouds Q4 Earnings Beat

Merck said it sees 2023 sales in the region of $57.2 billion and $58.7 billion.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations